By GREGORY ZELLER //
The former chief executive of the Mayo Clinic will head Northwell Health and Aegis Ventures’ latest innovative enterprise.
Northwell Holdings, the New Hyde Park-based health system’s for-profit investment subsidiary, and Aegis Ventures, a New York City-based company-creation platform (and frequent Northwell partner), have tapped John Noseworthy for a “key leadership role” at the Caire Collaborative.
The collaborative is a consortium of health systems that are all investors, early adopters and/or clinical partners of Caire, an innovative virtual-care ecosystem spearheaded by Northwell Health President and CEO Michael Dowling.
A neurologist by trade, Noseworthy is the president and CEO emeritus of the Minnesota-based Mayo Clinic, after officially filling those roles at the famous academic medical center from 2009 to 2018.
He also is the former editor-in-chief of Neurology, the official journal of the American Academy of Neurology, and advised Donald Trump on healthcare issues early in the ex-president’s term.
Michael Dowling: Unique position.
As executive chairman of the Caire Collaborative, the longtime telemedicine proponent will work closely with partnering health systems on adapting and maximizing Caire’s integrated model of care delivery, which adds leading virtual-medicine solutions to each system’s boots-on-the-ground resources.
Focusing first on women’s health, Caire creates a common operating system for AI-enabled virtual-care products, with the ultimate goal of improving patient access, addressing care gaps and otherwise taking a tech-enabled approach to whole-person healthcare.
These are all ideas that came to the forefront during the COVID lockdown, according to Noseworthy, who noted he’s “excited to use my knowledge and industry experience to help create the future of healthcare.”
“The pandemic opened the door to a hybrid healthcare model,” the executive chairman said. “It is estimated that 20 to 50 percent of care can now be delivered virtually.
“I want to see health systems at the center of that progress, identifying the most critical healthcare issues that can be addressed by innovation, artificial intelligence and digital tools,” Noseworthy added. “We can and should take advantage of new technology to address the gaps and disparities in care that we weren’t able to manage before.”
Enter Caire, designed to support a patient’s individual care journey and address critical industry-wide employer issues like clinician burnout and staff turnover, all by streamlining healthcare operations.
The health-tech startup continues a hot streak for the Northwell Holdings/Aegis Ventures strategic partnership, following the partners’ 2021 announcement of plans for a unique AI-development platform; the 2022 debut of said platform, known by the stage name Ascertain; the subsequent launch of women’s health virtual-care startup Upliv; and last month’s introduction of Ascertain import Optain, bringing advanced retinal-imaging tech from Australia.
Across the board, the rapid progress leverages field-level innovation and “inter-health system collaboration” – and the Caire model continues those imperatives in spades, according to Dowling.
“Health systems are uniquely positioned to innovate a new model that combines virtual and in-person care,” the CEO said. “By putting hospitals at the center of digital health innovation, we will preserve access to the critical health services our communities rely on, and usher in a new era of seamless care coordination for our patients.”
